Novartis KSA, SSDDS and SAAIS Join Efforts to Raise Awareness of Chronic Spontaneous Urticaria
Ahmed Bin Abdulqader – nabd-alhadath
- The nationwide roadshow underscores a shared commitment to advancing health outcomes by fostering educational platforms, enhancing dialogue across the healthcare ecosystem, and strengthening public-private partnerships.
Novartis Saudi Arabia, in collaboration with the Saudi Society of Dermatology and Dermatologic Surgery (SSDDS) and the Saudi Allergy Asthma & Immunology Society (SAAIS), today kicked off a nationwide roadshow to raise awareness and advance understanding of chronic spontaneous urticaria (CSU).
The initiative commenced in Jeddah and will continue across Riyadh and other cities in the Kingdom over the coming months, bringing together healthcare professionals and stakeholders through a series of educational and awareness-focused engagements.
The roadshow forms part of Novartis Saudi Arabia’s ongoing collaboration with the Saudi Society of Dermatology and Dermatologic Surgery and reflects a shared commitment to advancing awareness, fostering dialogue, and supporting continued education within the healthcare community.
“At Novartis, our purpose is to reimagine medicine to improve and extend people’s lives. Transforming the patient journey requires strong, collaborative platforms that bring together expertise, resources, and shared vision,” said Amir Abdelaziz, Country President at Novartis Saudi Arabia. “By partnering with esteemed organizations like the SSDDS and SAAIS, we are taking an important step forward in driving nationwide awareness, empowering the healthcare community, and supporting the Kingdom’s overarching health sector transformation goals.”
Dr. Louai Salah, Board Member, Saudi Society of Dermatology and Dermatologic Surgery, said: “Raising awareness and exchanging scientific insights across medical communities are vital to elevating standards of care. Our ongoing collaboration with Novartis Saudi Arabia reflects a joint dedication to advancing education and supporting healthcare professionals with the knowledge needed to better serve patients across the Kingdom. Initiatives like this roadshow provide an essential platform to deepen understanding and strengthen clinical engagement.”
Dr. Loie Tallat Goronfolah, Board Member, Saudi Allergy Asthma & Immunology Society, said: “Public-private partnerships play a pivotal role in creating sustainable impact within Saudi Arabia’s healthcare landscape. By joining forces on this nationwide effort, we are facilitating valuable educational exchanges and reinforcing the importance of early recognition and coordinated care. We remain committed to supporting initiatives that align with national health priorities and elevate patient care standards nationwide.”
Novartis Saudi Arabia and its partners will continue to engage healthcare stakeholders across the region, establishing sustainable frameworks for knowledge sharing that ultimate serve to elevate the standard of patient care.
Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.
